24 October 2023
-
World Health Summit unveils COP28 declaration on climate and health
GERMANY — As Dubai gears up to host COP28, significant revelations emerged from the World Health Summit held in Berlin from October 15-17, 2023. This…
-
Private Equity firms eye acquisition of Indian pharma company, Inventia Healthcare
INDIA — Multiple global and domestic private equity funds, including Apax Partners, TPG Capital, TA Associates, and Kedaara Capital, are reportedly in initial talks about…
-
Glenmark Pharmaceuticals introduces innovative triple-drug combination for type 2 diabetes
INDIA — Glenmark Pharmaceuticals has launched a triple-drug fixed-dose combination (FDC) in India, known as Zita DM. This innovative FDC combines Teneligliptin (20mg), Dapagliflozin (10mg),…
-
WHO takes action to address sexual misconduct complaints and foster accountability
AFRICA — The World Health Organization (WHO) has been grappling with sexual misconduct complaints across its various regions, shedding light on the prevalence of such…
-
Pfizer’s new meningococcal vaccine, Penbraya, approved for broader protection in teens and young adults
USA — In a recent development, the Food and Drug Administration (FDA) granted approval for Pfizer’s Penbraya, a groundbreaking meningococcal vaccine. This approval extends the…
-
Roche secures multi-billion-dollar acquisition to bolster inflammatory bowel disease portfolio
USA — Roche, a leading Swiss pharmaceutical company, has announced a significant acquisition that solidifies its position in the inflammatory bowel disease market. The deal,…